David Wright, Co-founder and CTO

David is an expert in molecular modelling and simulation with over 8 years postdoctoral experience at University College London researching the use of modelling and simulation in complex biological systems and applying this to systems that can better predict resistance to small molecule cancer drugs.

Since 2017 David has had senior technology leadership experience in AI biotech companies and co-founded Kuano in 2020.

David holds a PhD in Chemistry from University College London

“One of my ambitions has long been to make good on the promise of computational approaches to develop new therapeutics. We have built Kuano from the ground up to leverage state of the art simulations to achieve this goal.”